STARTUP PROFILE

SpineX

COUNTRY
USA
FOUNDED
2018
CATEGORY
Neuromodulation
Delivering non-invasive spinal cord neuromodulation therapies (SCONE™, SCiP™) to treat neurogenic bladder, cerebral palsy, and related neurological impairments.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
SCS
FORM FACTOR
External device
INTERFACE DEPTH
Non-invasive
INDICATION
Paralysis/motor
TARGET USER
Patients
REGULATORY STAGE
Investigational
SpineX is developing non-invasive spinal cord stimulation systems across bladder dysfunction, cerebral palsy, and related impairments, placing it in restorative neurorehabilitation rather than pain-focused SCS. Its pediatric relevance gives it a distinctive clinical positioning.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
SpineX
No items found.